SARS News and Research

RSS

Using 'own' immune cells to fight infectious diseases including COVID-19

A provocative paper from Duke-NUS Medical School, published in the Journal of Experimental Medicine in March 2020, discusses the possibilities of creating new receptors on a sick person's own immune cells as a means of controlling the infection. This therapy is already being used to treat certain cancers with marked success.

22 Apr 2020

Coronavirus has mutated into at least 30 variants

The coronavirus disease (COVID-19) continues to threaten millions of people across the globe, and lockdowns appear set to remain in place in many countries amid rising death tolls, as governments decide whether to extend restrictions aimed at reducing the spread of the virus. Now, a new study reveals that the novel coronavirus has mutated into at least 30 different genetic variants, affecting different parts of the world.

22 Apr 2020

Lifting the lid on coronavirus flatulence

The highly infectious virus is spread via aerosols (droplets of saliva or nasal discharge spread by coughing or sneezing by the infected person with the mouth uncovered). New speculation reveals that it could spread via fecal matter and even via farts or flatulence. Researchers believe that there is some truth to this speculation.

22 Apr 2020

Antibodies to COVID-19 present in only 2 to 3 percent of population

This week on Monday (20th April 2020), in a press meet, the World Health Organization (WHO) Director-General said that only around 2 to 3 percent of the global population have antibodies that show they had been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease.

22 Apr 2020

Scientists identify cells likely targeted by novel coronavirus

Researchers at MIT; the Ragon Institute of MGH, MIT, and Harvard; and the Broad Institute of MIT and Harvard; along with colleagues from around the world have identified specific types of cells that appear to be targets of the coronavirus that is causing the Covid-19 pandemic.

22 Apr 2020

Computers join the battle against novel coronavirus

Scientists everywhere are banding together to fight the novel coronavirus, and they're already making progress.

22 Apr 2020

Individualized vent-splitter may allow multiple COVID-19 patients to share single ventilator

As the pandemic swept across the nation in March, so did urgent questions about the virus' potential strain on the healthcare system.

22 Apr 2020

COVID-19 unlikely to be transmitted through semen, study shows

COVID-19 is unlikely to be spread through semen, according to University of Utah Health scientists who participated in an international study of Chinese men who recently had the disease.

22 Apr 2020

A first-in-human trial with promising MERS coronavirus vaccine

Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths.

22 Apr 2020

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta Group plc is pleased to announce that it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen.

From Avacta Life Sciences Ltd. 22 Apr 2020

Scripps Research established international network to find antiviral compounds against COVID-19

With the COVID-19 pandemic continuing to spread around the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.

22 Apr 2020

Nanoengineers are using plant virus to develop COVID-19 vaccine

Nanoengineers at the University of California San Diego are working on a COVID-19 vaccine using an unconventional candidate: a plant virus.

22 Apr 2020

Scientists identify new mechanisms that offer protection against Marburg infection

A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center.

22 Apr 2020

Antibody testing in L.A. county reveals the magnitude of coronavirus spread

After weeks of physical and social distancing measures in place, many in the U.S. are worrying about how soon they can return to normal life. However, to lift restrictions, it is critical to ascertain accurate numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carriers. Doing so will decrease the chance or even avoid the second wave of infections.

22 Apr 2020

Experts share contingency plans to address increased COVID-19 cases in urban areas

In "Mobilization and Preparation of a Large Urban Academic Center During the COVID-19 Pandemic,"- published online in the Annals of the American Thoracic Society - experts from Philadelphia's Temple University Hospital share their contingency plans for meeting an increased demand for hospitalization, as well as their protocols and training plans to minimize health care staff exposure to COVID-19 and ensure proper active and reserve staffing.

22 Apr 2020

Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers

Grifols, a global healthcare company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines, today announced it has begun identifying, screening and selecting volunteer donors who have recovered from COVID-19 to donate their plasma in select U.S. cities.

22 Apr 2020

Research offers clues to how SARS-CoV-2 gets into respiratory tissue and exploits our defenses

What makes SARS-CoV-2, the virus behind COVID-19, such a threat? A new study, led by Jose Ordovas-Montanes, Ph.D. at Boston Children's Hospital and Alex K. Shalek, Ph.D. at MIT, pinpoints the likely cell types the virus infects.

22 Apr 2020

Nanostics to create new blood test to forecast the severity of COVID-19 in patients

Nanostics Inc., a diagnostic healthcare company that focuses on developing tests to determine a patient's disease risk, announced today plans to develop and validate ClarityDX COVID-19; a simple blood test to predict the severity of COVID-19 disease in patients.

22 Apr 2020

Researchers design UV sterilization stations to kill coronavirus on any surface

As the COVID-19 pandemic continues into its second month across the U.S., supplies of personal protective equipment such as N95 masks and face shields continue to run low at many hospitals.

22 Apr 2020

Is hydroxychloroquine effective against COVID-19?

Following the emergence of a novel coronavirus in Wuhan, China, in the last month of 2019, it has spread globally to produce the first pandemic of the 21st century. The virus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already affected over 2.5 million and killed more than 177,000 people as of April 22, 2020.

22 Apr 2020

SARS News and Research

Using 'own' immune cells to fight infectious diseases including COVID-19

Coronavirus has mutated into at least 30 variants

Lifting the lid on coronavirus flatulence

Antibodies to COVID-19 present in only 2 to 3 percent of population

Scientists identify cells likely targeted by novel coronavirus

Computers join the battle against novel coronavirus

Individualized vent-splitter may allow multiple COVID-19 patients to share single ventilator

COVID-19 unlikely to be transmitted through semen, study shows

A first-in-human trial with promising MERS coronavirus vaccine

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Scripps Research established international network to find antiviral compounds against COVID-19

Nanoengineers are using plant virus to develop COVID-19 vaccine

Scientists identify new mechanisms that offer protection against Marburg infection

Antibody testing in L.A. county reveals the magnitude of coronavirus spread

Experts share contingency plans to address increased COVID-19 cases in urban areas

Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers

Research offers clues to how SARS-CoV-2 gets into respiratory tissue and exploits our defenses

Nanostics to create new blood test to forecast the severity of COVID-19 in patients

Researchers design UV sterilization stations to kill coronavirus on any surface

Is hydroxychloroquine effective against COVID-19?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News